KHALID EBRAHIM: Open Payments
NPI 1346637634 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,033 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,033
Food & beverage: $2,020Travel & lodging: $13
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 2 | $1,770 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $125 |
| PFIZER INC. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Rapiblyk, LifeVest, VYNDAQEL, ULTOMIRIS, VOWST, JOURNAVX, JARDIANCE, XIFAXAN.
Industry payments across DC — which companies pay providers there.
